PlainRecalls

Lusys Laboratories, Inc.

Compiled from official public sources by the publisher.

11 recalls on record · Latest: Mar 16, 2022

Subscribe to new Lusys Laboratories, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Lusys Laboratories, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,364 of 14,151 · 11 notices · 0.011% archive

  • BOOK 11 notices
  • RANK #1,364 of 14,151
  • SHARE 0.011% archive
  • AGENCY FDA Devices (11)
  • CAT medical devices
  • CATS 1 category
  • LATEST Mar 16, 2022
  • PHOTO Agfa Corp.

Nearest notice-volume peer: Agfa Corp. (0 notice gap)

Lusys Laboratories, Inc. accounts for about 0.011% of the 104,423-notice archive on 11 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Lusys Laboratories, Inc. sits among 14,151 recalling firms

Lusys Laboratories, Inc. ranks 1,364th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Lusys Laboratories, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

11 1364th of 14151 higher than 12,735 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-23

Lusys Laboratories, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Lusys Laboratories, Inc. holds about 0.011% of archive notices alongside 11 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Critical Mar 16, 2022

Luscient Diagnostics 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Nasal Swab Test)
FDA Devices Critical Mar 16, 2022

LuSys 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Saliva Test)
FDA Devices Critical Mar 16, 2022

COVID-19 IgG/IGM Antibody Test For Detection of COVID-19 IgG and IgM antibodies Catalog No: I-111
FDA Devices Critical Apr 15, 2015

Ebola GP IgX Blood, Serum, Plasma, Cassette, Catalog No. I-101 Materials Provided: 1. Test Device 2. Lancet (optional) 3. Alcohol pad. (optional) 4. Extraction tube (optional) 5. Buffer vial (0.5ml) --- packaged separately, and sufficient for use with up to 40 tests.
FDA Devices Critical Apr 15, 2015

Ebola Virus Antigen Blood, Catalog No. I-123 (A) Materials Provided: 1. Test Device in foil pouch. 2. Lancet for Blood test and alcohol pad. 3. Extraction tube contain buffer vial (0.5ml) for feces test 4. Swab for Nasal test.
FDA Devices Critical Apr 15, 2015

Ebola Virus GP-VP IgS, Catalog No. I-124 virus test kit
FDA Devices Critical Apr 15, 2015

Ebola VP-40 IgG/IgM (Blood Serum/Plasma/Cassette), Catalog No. I-102 Materials Provided: 1. Test Device 2. Lancet (optional) 3. Alcohol pad. (optional) 4. Extraction tube (optional) 5. Buffer vial (0.5ml) --- packaged
FDA Devices Critical Apr 15, 2015

Ebola Virus Antigen Nasal , Catalog No. I-123 (B) Materials Provided: 1. Test Device in foil pouch. 2. Lancet for Blood test and alcohol pad. 3. Extraction tube contain buffer vial(0.5ml) for feces test 4. Swab for Nasal test.
FDA Devices Critical Apr 15, 2015

Ebola IgX VP-40 Serum/Plasma/Blood Cassette, Catalog No. I-100 Materials Provided: 1. Test Device 2. Lancet 3. Alcohol pad. 4. Develop buffer tube contain buffer vial (0.3ml)
FDA Devices Critical Apr 15, 2015

Ebola Accessories assembled, self-contained package, Catalog No. I-104 virus test kit
FDA Devices Critical Apr 15, 2015

Ebola GP IgM Blood (Blood Serum/Plasma/Cassette), Catalog No. I-103 virus test kit

Lusys Laboratories, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (11 here — thin-book).

Agfa Corp. 11 Akron Pharma, Inc. 11 Amendia, Inc 11 Aniara Diagnostica LLC 11 Arg Laboratories, Inc. 11

Similar medical devices volume

Nearest multi-notice firms in the same narrow category lane.

Agfa Corp. 11 Amendia, Inc 11 Aniara Diagnostica LLC 11 Arjohuntleigh Polska Sp. z.o.o. 11

Frequently Asked Questions

How many federal recall notices name Lusys Laboratories, Inc.? ▼
PlainRecalls indexes 11 distinct federal recall events naming Lusys Laboratories, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Lusys Laboratories, Inc. sit among other recalling firms? ▼
Lusys Laboratories, Inc. ranks #1,364 of 14,151 by distinct recall-event count among 14,151 firms in this archive (90th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Lusys Laboratories, Inc.'s notices? ▼
FDA Devices accounts for 11 of this firm's 11 indexed notices.
What product category dominates Lusys Laboratories, Inc.'s filing book? ▼
Filings for Lusys Laboratories, Inc. span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Lusys Laboratories, Inc.: 11 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Lusys Laboratories, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026